BMRN vs CLF · P/E 40, rev $2.85B vs rev $19.18B
Biomarin Pharmaceutical Inc (BMRN) versus Cleveland-Cliffs Inc (CLF) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Cleveland-Cliffs Inc (CLF) is a steel company listed on US.
Latest reported BMRN revenue for 2024-12-31 was $2.85B. Net income was $426.9M. Revenue was up 18.0% from 2023-12-31 to 2024-12-31. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported CLF revenue for 2024-12-31 was $19.18B. Net income was -$708.0M. Revenue was down 12.8% from 2023-12-31 to 2024-12-31. CLF currently screens at market cap $8.07B.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. CLF currently screens at market cap $8.07B.
Not investment advice. Open the BMRN and CLF stock pages for the full models.
Not investment advice.